Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the most promising stocks under $100 to buy. On March 16, Mirum ...
Everyday Health on MSN
Why primary biliary cholangitis causes itching — and how to find relief
Learn why primary biliary cholangitis (PBC) causes intense itching, and explore treatment options, management tips, and skin-care strategies for relief.
Everyday Health on MSN
What causes primary biliary cholangitis fatigue — and how to get your energy back
Learn about the link between primary biliary cholangitis (PBC) and fatigue, and get tips to restore energy and improve your daily life.
Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary cholangitis.
GSK PLC on Thursday said the US Food & Drug Administration approved Lynavoy for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. The London-based pharmaceutical ...
MIRM completes enrollment in phase III EXPAND study of Livmarli for treating additional rare cholestatic liver diseases. Top-line data due in Q4 2026.
Former News 12 anchor Amy McGorry is urgently seeking a living liver donor as she battles serious liver disease and pleads for help.
The double-blind, randomised, placebo-controlled trial will assess the efficacy and safety of Livmarli in both children and ...
Bloating after meals. Cramping that seems to come and go. Diarrhea one week, constipation the next. These are symptoms heard ...
Recent studies show that coffee consumption’s role in gastrointestinal disorders, from GERD to cancer, is nuanced, ...
GSK and Alfasigma have signed a licensing agreement granting Alfasigma worldwide exclusive rights to develop, manufacture and commercialise linerixibat, an investigational IBAT inhibitor for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results